ArticleBreast cancer research : BCR2025

Erdafitinib inhibits the tumorigenicity of MDA-MB-231 triple-negative breast cancer cells by inducing TRIM25/ubiquitin-dependent degradation of FGFR4.

Qing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.